Form 4 for PHAT Phathom Pharmaceuticals, Inc.
Accepted 2023-06-05 00:00:00 ET · period of report 2023-06-02 · accession 0001209191-23-034616 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-05 | 2023-06-02 | PHAT | Parikh Asit | Dir | A - Grant | $7.40 | +15.0K | 47.5K | +46% | +$111.0K |
| D | 2023-06-05 | 2023-06-02 | PHAT | Parikh Asit | Dir | D - Sale to Iss | $0.00 | -15.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-02 | A | A | 15,000 | $7.40 | 47,500 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-06-02 | D | D | 15,000 | $0.00 | 0 | D | $7.40 · — to 2032-05-24 | 15,000 Common Stock | (F1) The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program and vested/became exercisable on the first anniversary of the date of grant. |